Show Summary Details
Page of

Schizophrenia and paranoid disorders in late life 

Schizophrenia and paranoid disorders in late life
Schizophrenia and paranoid disorders in late life

Barton W. Palmer

, Gauri N. Savla

, and Thomas W. Meeks

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2022. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 16 May 2022

Estimates of the point-prevalence of paranoia and other psychotic symptoms among persons age ⋚ 65 years have ranged from approximately 4 per cent to 6 per cent, and may be as high as 10 per cent among those age ⋚ 85 years. Although the majority of these symptoms occur as secondary psychoses in the context of Alzheimer’s disease or related dementias, the population of people with schizophrenia is ageing along with the general ‘greying’ of the industrialized world, and mental health care for older adults with schizophrenia is expected to be an increasingly important public health concern. This chapter covers clinical features, classification systems, diagnosis and differential diagnosis, epidemiology, aetiology, course and prognosis, treatment, and management.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.